BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3936 related articles for article (PubMed ID: 23046836)

  • 21. [ECRIN (European clinical research infrastructures network), a pan-European infrastructure for clinical research].
    Demotes-Mainard J
    Bull Acad Natl Med; 2010 Dec; 194(9):1683-94. PubMed ID: 22043593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New strategies for innovation in global health: a pharmaceutical industry perspective.
    Witty A
    Health Aff (Millwood); 2011 Jan; 30(1):118-26. PubMed ID: 21209447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chinese villages and their sustainable future: the European Union-China-Research Project "SUCCESS".
    Dumreicher H
    J Environ Manage; 2008 Apr; 87(2):204-15. PubMed ID: 17888563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. European Union vaccine research--an overview.
    Sautter J; Olesen OF; Bray J; Draghia-Akli R
    Vaccine; 2011 Sep; 29(39):6723-7. PubMed ID: 21195799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Consensus document on European brain research.
    Olesen J; Baker MG; Freund T; di Luca M; Mendlewicz J; Ragan I; Westphal M
    J Neurol Neurosurg Psychiatry; 2006 Aug; 77 Suppl 1(Suppl 1):i1-49. PubMed ID: 16845120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beware the Medical-Industrial Complex.
    Stevens CW; Glatstein E
    Oncologist; 1996; 1(4):IV-V. PubMed ID: 10388005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Community-university partnerships in occupational therapy education: a preliminary exploration of practice in a European context.
    McGrath M; Moldes IV; Fransen H; Hofstede-Wessels S; Lilienberg K
    Disabil Rehabil; 2014; 36(4):344-52. PubMed ID: 23639068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Technological innovation, human capital and social change for sustainability. Lessons learnt from the industrial technologies theme of the EU's Research Framework Programme.
    Sabadie JA
    Sci Total Environ; 2014 May; 481():668-73. PubMed ID: 24149071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new paradigm for improved co-ordination and efficacy of European biomedical research: taking diabetes as a model.
    Halban PA; Boulton AJ; Smith U
    Diabetologia; 2013 Mar; 56(3):439-43. PubMed ID: 23238786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expert Group Meeting on Family Planning, Health and Family Well-Being.
    Popul Bull UN; 1993; (34-35):79-101. PubMed ID: 12287717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Productive university, industry, and government relationships in preclinical drug discovery and development: considerations toward a synergistic lingua franca.
    Janero DR
    Expert Opin Drug Discov; 2012 Jun; 7(6):449-56. PubMed ID: 22540843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The university and "health for all by the year 2000"].
    Guerra de Macedo C
    Educ Med Salud; 1985; 19(3):259-65. PubMed ID: 4076041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reducing obesity and related chronic disease risk in children and youth: a synthesis of evidence with 'best practice' recommendations.
    Flynn MA; McNeil DA; Maloff B; Mutasingwa D; Wu M; Ford C; Tough SC
    Obes Rev; 2006 Feb; 7 Suppl 1():7-66. PubMed ID: 16371076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implementing and using quality measures for children's health care: perspectives on the state of the practice.
    Shaller D
    Pediatrics; 2004 Jan; 113(1 Pt 2):217-27. PubMed ID: 14702504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The PCAST report on pharmaceutical innovation: implications for the FDA.
    Woodcock J
    Clin Pharmacol Ther; 2013 Sep; 94(3):297-300. PubMed ID: 23963215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promoting drug discovery by collaborative innovation: a novel risk- and reward-sharing partnership between the German Cancer Research Center and Bayer HealthCare.
    Wellenreuther R; Keppler D; Mumberg D; Ziegelbauer K; Lessl M
    Drug Discov Today; 2012 Nov; 17(21-22):1242-8. PubMed ID: 22521665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug delivery research in the European Union's Seventh Framework Programme for Research.
    Frima HJ; Gabellieri C; Nilsson MI
    J Control Release; 2012 Jul; 161(2):409-15. PubMed ID: 22333557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. European initiative towards quality standards in education and training for discovery, development and use of medicines.
    Klech H; Brooksbank C; Price S; Verpillat P; Bühler FR; Dubois D; Haider N; Johnson C; Lindén HH; Payton T; Renn O; See W
    Eur J Pharm Sci; 2012 Apr; 45(5):515-20. PubMed ID: 22178534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of public-private partnerships in addressing the biomedical innovation challenge.
    Said M; Zerhouni E
    Nat Rev Drug Discov; 2014 Nov; 13(11):789-90. PubMed ID: 25359362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 197.